Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Levofloxacin; Levofloxacin; and Levofloxacin marketed formulations · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Levofloxacin oral suspension; Levofloxacin oral solution; and Levofloxacin marketed tablet formulations | DRUG | - |
Inclusion Criteria: * Men and women * Aged 18 to 55 years * BMI between 18 and 30 kg/m2 * No prescription or over-the-counter medications for previous 14 days * Negative tests for drug and alcohol abuse, HIV, hepatitis B and hepatitis C * and Healthy based on medical history, physical examination, ...